Objectively measured far vision impairment and sarcopenia among adults aged ≥ 65 years from six low- and middle-income countries.


Smith L., López-Sánchez G. F., Jacob L., Barnett Y., Pardhan S., Veronese N., ...More

Aging clinical and experimental research, vol.33, no.11, pp.2995-3003, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 33 Issue: 11
  • Publication Date: 2021
  • Doi Number: 10.1007/s40520-021-01841-y
  • Journal Name: Aging clinical and experimental research
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Abstracts in Social Gerontology, AgeLine, CAB Abstracts, CINAHL, EMBASE, MEDLINE
  • Page Numbers: pp.2995-3003
  • Keywords: Sarcopenia, Visual impairment, Low, and middle-income countries, Older adults, Far vision impairment, WORLD-HEALTH-ORGANIZATION, OLDER-ADULTS, VISUAL IMPAIRMENT, INFLUENTIAL FACTORS, SEDENTARY BEHAVIOR, PHYSICAL-ACTIVITY, MUSCLE MASS, LIFE-SPAN, DISABILITY, PREVALENCE
  • Bezmialem Vakıf University Affiliated: Yes

Abstract

Background There are currently no studies on visual impairment and sarcopenia. We investigated the cross-sectional association between objectively measured far vision impairment and sarcopenia in a nationally representative sample of older adults aged 65 years and over from six low- and middle-income countries (LMICs). Methods Cross-sectional, community-based data from the study on global ageing and adult health (SAGE) were analyzed. Far vision acuity was measured using the tumbling E LogMAR chart and classified as: no vision impairment (6/12 or better); mild vision impairment (6/18 or better but worse than 6/12); moderate vision impairment (6/60 or better but worse than 6/18); severe vision impairment (worse than 6/60). Sarcopenia was defined as having low skeletal muscle mass and either a slow gait speed or a weak handgrip strength. Associations were assessed with multivariable logistic regression. Results Fourteen thousand five hundred and eighty five individuals aged >= 65 years were included in the analysis [mean (SD) age 72.6 (11.5) years; 54.1% females]. After adjustment for multiple potential confounders, compared to those with no vision impairment, the OR (95% CI) for sarcopenia in those with mild, moderate, and severe vision impairment were 1.10 (0.87-1.40), 1.69 (1.25-2.27), and 3.38 (1.69-6.77), respectively. The estimates for females and males were similar. Conclusions The odds for sarcopenia increased with increasing severity of far vision impairment among older people in LMICs. The mere co-occurrence of these conditions is concerning, and it may be prudent to implement interventions to address/prevent sarcopenia in those with far vision impairment through the promotion of physical activity and appropriate nutrition.